Irritable bowel syndrome
Conditions
Interventions
Intervention group 1:Oral trimetbutine maleate capsules plus mimetic umbilical moxibustion
Control group:Oral trimeibutine maleate capsules
Intervention group 2:Oral administration of trimeibutin maleate capsules plus Gui Shaosan umbilical moxibustion
Sponsors
Jiangsu Provincial Hospital of Integrated Chinese and Western Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 59 Years
Inclusion criteria
Inclusion criteria: (1) Meet the Western medical diagnostic criteria of IBS-D and the TCM syndrome differentiation of liver depression and spleen deficiency syndrome in TCM; (2) Age 18~59 years old conscious; (3) Patients with informed consent and voluntary participation in this study.
Exclusion criteria
Exclusion criteria: (1) Patients with organic lesions of the gastrointestinal tract such as moderate to severe peptic ulcer erosion swelling cancer intestinal metaplasia or dysplasia; (2) Patients with severe cardiovascular and cerebrovascular liver kidney and other primary diseases coagulation dysfunction and tumors; (3) Psychiatric patients and patients with severe neurosis; (4) Women who are pregnant lactating or planning to become pregnant; (5) Those who have taken antibiotics or probiotic preparations or gastrointestinal prokinetic drugs within 1 month before the inclusion of the trial; (6) Patients with poor compliance with medical instructions and intolerance to moxibustion; (7) Those with allergies and allergies to the ingredients of medicinal powder; (8) Patients who are participating in other clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM Pattern Grading Criteria;self-rating anxiety scale(SAS);self-rating depression scale(SDS);TCM Clinical Symptom Score;IBS Quality of Life Scale Score (IBS-QOL);IBS severity scale score(IBS-SSS); | — |
Countries
China
Contacts
Public Contactzhangxixia
Jiangsu Provincial Hospital of Integrated Chinese and Western Medicine
Outcome results
None listed